Ennaid Therapeutics | African American Drug Company Founder Announces Possible Coronavirus Treatment
19537
post-template-default,single,single-post,postid-19537,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-6.2.0,vc_non_responsive

African American Drug Company Founder Announces Possible Coronavirus Treatment

09 Apr African American Drug Company Founder Announces Possible Coronavirus Treatment

Ennaid Therapeutics is seeking FDA approval for drug that could help the afflicted.

A Georgia-based pharmaceutical company is advancing the development of an antiviral drug that may potentially fight coronavirus cases, and which would be more easily administered to those afflicted by the disease.

Darnisha Harrison, founder and CEO of Ennaid Therapeutics, one of the first African American women to start a major drug company, announced her company filed a patent when scientists working there created a therapeutic called ENU200 that could treat as much as 80 percent of asymptomatic, mild to moderate COVID-19 infections.

Read the full write up on BET’s website HERE

No Comments

Post A Comment